Enclomiphene represents a fundamentally different approach to low testosterone: instead of replacing testosterone from the outside (TRT), it stimulates the body's own production from the inside. For men choosing between the two, the decision involves trade-offs in testosterone levels achieved, fertility impact, convenience, and long-term commitment.
How They Compare
| Factor | TRT (Injectable Cypionate) | Enclomiphene Monotherapy |
|---|---|---|
| Testosterone increase | Dose-dependent; typically 500–800+ ng/dL at trough | Typically 200–350 ng/dL increase from baseline |
| Fertility | Suppresses (requires HCG to mitigate) | Preserves or improves |
| HPG axis | Suppresses (may not fully recover if stopped) | Enhances (axis remains active) |
| Route | Injection (weekly/twice-weekly) | Oral (daily pill) |
| FDA status | Approved for hypogonadism | Not FDA-approved; available compounded |
| Testicular volume | Shrinks | Maintains or increases |
| Cost | $99–$250/mo | $50–$120/mo (compounded) |
| Estradiol management | May require AI or frequency adjustment | Generally self-regulating (intact feedback) |
Who Should Choose Enclomiphene
Enclomiphene Candidates
- Men with secondary hypogonadism (low T, low/normal LH) — the mechanism specifically targets this
- Men who want to preserve fertility without adding HCG to a TRT regimen
- Men who prefer oral medication over injection
- Men who want the option of stopping therapy without HPG axis recovery concerns
- Men who need modest testosterone improvement (200–350 ng/dL increase) rather than high-normal targeting
Who Should Choose TRT
TRT is better for: Men who need maximum testosterone elevation (severe hypogonadism, T below 200), men with primary hypogonadism (testicular failure — enclomiphene won't work if the testes can't respond to LH), men who've completed their families and don't need fertility preservation, and men who want the most extensively studied and guideline-supported treatment.
The Bottom Line
Different Tools for Different Situations
Enclomiphene and TRT aren't competing treatments — they're different tools for different clinical scenarios. Enclomiphene is ideal for younger men with secondary hypogonadism who want fertility preservation and modest testosterone improvement. TRT is superior for men who need maximum testosterone elevation, have primary hypogonadism, or don't need to preserve reproductive function. The best choice depends on your specific diagnosis, fertility goals, and testosterone target.